Cancer Research UK logo.
SearchDonate
  • Search

A study of MIV-818 for liver cancer

Overview

Cancer types:

Liver cancer, Secondary cancers

Status:

Closed

Phase:

Phase 1/2

Details

This study is looking at MIV-818 in combination with lenvatinib or pembrolizumab for people with .

Recruitment start: 5 September 2018

Recruitment end: 31 August 2023

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Ruth Plummer

Supported by

Medivir

Last reviewed: 29 Dec 2023

CRUK internal database number: 16921

Help and support